subscribeSubscribe
Eiger Begins Enrollment in LIMT-2 Phase 3 Study of Peginterferon Lambda

Eiger Begins Enrollment in LIMT-2 Phase 3 Study of Peginterferon Lambda
PRNEWSWIRE
21 Dec 2021
Share Share
Triple drug combination shows promise in Covid-19 treatment

Triple drug combination shows promise in Covid-19 treatment
CLINICALTRIALSARENA
11 May 2020
Share Share
Bausch Health initiates VIRAZOLE trial in Covid-19 patients

Bausch Health initiates VIRAZOLE trial in Covid-19 patients
CLINICALTRIALSARENA
15 Apr 2020
Share Share
Bausch Health begins clinical study in Canada evaluating Virazole in combo

Bausch Health begins clinical study in Canada evaluating Virazole in combo
PHARMABIZ
13 Apr 2020
Share Share
Can old drugs take down a new coronavirus?

Can old drugs take down a new coronavirus?
Lisa M. Jarvis C&EN
13 Mar 2020
Share Share
Biogen Idec`s Plegridy (Peginterferon beta-1a) Receives Supplemental Approval In US

Biogen Idec`s Plegridy (Peginterferon beta-1a) Receives Supplemental Approval In US
12 Jul 2019
Share Share
AbbVie reports 99% cure rate for pan-genotypic Hep C therapy

AbbVie reports 99% cure rate for pan-genotypic Hep C therapy
Selina McKee PHARMA TIMES
21 Apr 2017
Share Share
Japan Grants Priority Review to AbbVie`s Investigational Regimen

Japan Grants Priority Review to AbbVie`s Investigational Regimen
DDDMAG
25 Mar 2017
Share Share
Aviragen takes a tumble as RSV drug fails mid-stage trial

Aviragen takes a tumble as RSV drug fails mid-stage trial
Phil Taylor  FIERCE BIOTECH
02 Feb 2017
Share Share
SMC OKs four new therapies for NHS use in Scotland

SMC OKs four new therapies for NHS use in Scotland
Selina McKee PHARMATIMES
18 Jan 2017
Share Share